Deepak Nitrite Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 4 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹23.7K Cr

Cautious optimism about H2 FY26, expecting better performance than Q2 due to improving market and demand sentiment. The company is cautiously optimistic about H2 FY26, expecting better demand and market sentiment compared to Q2.

From Deepak Nitrite Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

₹1,747

Market Cap

₹23.7K Cr

P/E Ratio

29.9

How does Deepak Nitrite Ltd rank in Chemicals & Petrochemicals?

Compare Deepak Nitrite Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Deepak Nitrite Ltd — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹220 Cr.

Full financials →

📊 Revenue & Sales Performance

→Cautious optimism about H2 FY26, expecting better performance than Q2 due to improving market and demand sentiment. (Page 18)
→Phenol volume growth was moderate (2-3%) in Q2; potential for increased output in H2 aided by cooler climate and operational efficiencies. (Page 9)
→Continuous debottlenecking efforts leading to volume growth beyond previous 10% capacity increase; further improvements targeted with low CAPEX. (Page 9)
→Advanced Intermediates segment expecting recovery and better trajectory in H2 FY26, with new products starting production and ramp-up towards Q4 FY26 and FY27. (Page 13)
→Ongoing projects like Nitric Acid, MIBK/MIBC plants and specialty chemicals nearing commissioning, expected to improve competitiveness and growth. (Page 6)
→Polycarbonate project commissioning targeted by March 2028, expected to enhance revenue over coming years. (Page 15-18)

📈 Profitability & Margins

→The company is cautiously optimistic about H2 FY26, expecting better demand and market sentiment compared to Q2.
→New product launches (7 in Q2) in Advanced Intermediates with good margin profiles are expected to significantly contribute to growth in FY27, especially in Q2 FY27.
→Ongoing commissioning of Nitric Acid, MIBK/MIBC, and specialty chemical plants will enhance competitiveness and margins.
→The integrated polycarbonate project commissioning is targeted for January-March 2028, expected to be a significant value driver.
→Cost control measures and fixed cost reductions are ongoing, supporting margin expansion.
→Operating efficiencies, including phenol plant debottlenecking, will yield moderate volume growth.
→The company expects improved profitability driven by operational excellence, innovation, and strategic investments in sustainability and integration.
→ROCE reported at 14%, reflecting capital-efficient operations.
→Revenue growth in H1 FY26 was stable; improvement is anticipated in the second half and FY27 with ramp-up of new products and projects.

🏗️ Capital Expenditure Plans

→Total capex over the next 3 years is around INR 9,000 crore.
→Planned capex breakdown: approximately INR 3,000-3,500 crore in FY26, and around INR 4,000 crore in FY27.
→Major investment is in the integrated polycarbonate project, targeting commissioning by March 2028.
→The project includes upstream products like Nitric Acid and downstream products like MIBK and MIBC to be operationalized in coming quarters.
→Investment includes acquisition of technology and assets for polycarbonate production (agreement signed with Trinseo).
→Appointed dismantling contractor and EPCM for polycarbonate project; groundwork and site development already started.
→Strategic discussions ongoing for utilities supply and optimization in integrated assets.
→Investment also in enhancing R&D capabilities with a state-of-the-art center focused on new molecule development and process intensification.
→Cost control measures are ongoing to improve fixed costs alongside capital investments.

💰 Fundraising & Capital Structure

→There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript.
→The Company maintains a strong balance sheet with low gearing (debt-to-equity of 0.21) and a net worth of INR 5,550 crore, supporting planned expansion.
→CAPEX plans over the next three years amount to around INR 9,000 crore, with INR 3,000-4,000 crore expected to be spent annually, but funding sources are not detailed.
→The Company emphasizes prudent capital allocation and disciplined execution to support growth.
→No clear statements regarding raising fresh debt or issuing equity were made during the call.

📋 Order Book & Pipeline

The transcript does not explicitly mention details about the current or expected order book or pending orders for Deepak Nitrite Limited. However, indirect insights can be noted: - Multiple agreements have been signed for licensing and technology for the phenol plant and polycarbonate resin production. - Advanced stages of discussions are ongoing for integrating certain utilities within the asset. - Dismantling and EPCM appointments for the polycarbonate project are underway, indicating active project execution. - Positive engagements with strategic partners in agrochemical intermediates and other specialty chemical areas hint at future order flows and collaborations. - The company mentions ongoing projects and new product launches, suggesting a healthy project pipeline. - Cautious optimism on improving demand in H2 FY26 implies potential for new orders or order recoveries. No quantifiable data on order book size or pending orders is provided.

Key Metrics

What Deepak Nitrite Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Indian Phosphate (Q2 FY26)
H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25. Key concall takeaways from Indian Phosphate's Q2 FY26 earnings call…
Alkyl Amines Chemicals Ltd (Q2 FY26)
120 crores. Key concall takeaways from Alkyl Amines Chemicals Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.
Sudarshan Chemical Industries Ltd (Q2 FY26)
The company completed a significant capex investment of roughly INR 700 crores about 3-4 years ago. Key concall takeaways from Sudarshan Chemical Industries…
Gujarat Narmada Valley Fertilizers & Chemicals Ltd (Q2 FY26)
Capex pipeline worth INR 2,800 crores includes expansions in AN melt, weak nitric acid, power and steam plant conversion, and ammonia loop expansion. Key…

Compare:vs Solar Industries India Ltd vs Pidilite Inds.vs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Deepak Nitrite Ltd Q2 FY26 results?

What is Deepak Nitrite Ltd share price analysis?

Deepak Nitrite Ltd currently shows a neutral. The stock trades at a P/E of 29.9 with a market cap of ₹23,687 Cr. Investors should review the full earnings analysis for detailed insights.

Is Deepak Nitrite Ltd planning capital expenditure?

Total capex over the next 3 years is around INR 9,000 crore.

Keep Deepak Nitrite Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.